The effect of moderate urine alkalinisation on low dose diethylcarbamazine therapy in patients with onchocerciasis.
Open Access
- 1 June 1986
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 21 (6) , 669-676
- https://doi.org/10.1111/j.1365-2125.1986.tb05232.x
Abstract
Twenty‐one patients with moderate to heavy infections with O. volvulus were treated with 25 mg of diethylcarbamazine (DEC) citrate twice daily for 10 days. In 11 patients the urine was made alkaline with sodium bicarbonate, 2 g, administered 6 hourly for three doses daily beginning 1 day before DEC was started and continued throughout the DEC therapy. Ten patients served as controls. The mean pre‐dose plasma DEC concentration during treatment and the mean plasma DEC half‐life were significantly higher in bicarbonate treated patients as compared to controls. Total urinary excretion of DEC was significantly less in the bicarbonate treated group than in controls. Mean overall total reaction was higher in bicarbonate‐treated patients but the difference was not significant. The bicarbonate‐treated group achieved a significantly greater reduction in skin microfilarial counts than the control group as assessed 1 week after completion of therapy, but there was little difference at 1 month. Microfilarial killing was associated with microfilarial mobilisation, alteration in peripheral leucocytes and elevation in serum aminotransferases in both groups. There was no effect of DEC on the number of adult worms recovered in nodules removed at the end of the therapy. This study indicates that moderate urinary alkalinisation alters the kinetics of DEC and the therapeutic response. However the severity of clinical reaction coupled with the inadequate level of microfilarial killing achieved make it unlikely that manipulation of urinary pH will be of practical value in onchocerciasis chemotherapy.This publication has 23 references indexed in Scilit:
- The chemotherapy of onchocerciasis VIIPathogens and Global Health, 1982
- The effect of variations in urinary pH on the pharmacokinetics of diethylcarbamazine.Published by Wiley ,1981
- Diethylcarbamazine disposition in patients with onchocerciasisClinical Pharmacology & Therapeutics, 1981
- Ocular changes with oral and transepidermal diethylcarbamazine therapy of onchocerciasis.British Journal of Ophthalmology, 1981
- Therapy of Tropical Diseases — FilariasisPublished by Springer Nature ,1980
- ADVERSE REACTIONS TO CUTANEOUS DIETHYLCARBAMAZINE IN ONCHOCERCIASISThe Lancet, 1979
- Effects of various concentrations of diethylcarbamazine citrate applied as eye drops in ocular onchocerciasis, and the possibilities of improved therapy from continuous non-pulsed delivery.British Journal of Ophthalmology, 1978
- Topical diethylcarbamazine in ocular onchocerciasisTransactions of the Royal Society of Tropical Medicine and Hygiene, 1973
- Topical Hetrazan in the Treatment of Ocular OnchocerciasisAmerican Journal of Ophthalmology, 1970